95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-199.50%
Negative revenue growth while PAAS stands at 17.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-199.50%
Negative gross profit growth while PAAS is at 218.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
-251.32%
Negative EBIT growth while PAAS is at 86.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-251.32%
Negative operating income growth while PAAS is at 86.00%. Joel Greenblatt would press for urgent turnaround measures.
-511.39%
Negative net income growth while PAAS stands at 92.47%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-511.27%
Negative EPS growth while PAAS is at 92.44%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-511.27%
Negative diluted EPS growth while PAAS is at 92.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1856.19%
OCF growth above 1.5x PAAS's 64.31%. David Dodd would confirm a clear edge in underlying cash generation.
1856.19%
FCF growth above 1.5x PAAS's 47.96%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-278.69%
Negative 10Y revenue/share CAGR while PAAS stands at 3684.54%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-278.69%
Negative 5Y CAGR while PAAS stands at 31.15%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36363820.17%
Negative 3Y CAGR while PAAS stands at 112.20%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.92%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31219.63%
Negative 3Y CAGR while PAAS is 84.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while PAAS shows 25.43%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while PAAS stands at 27.73%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-41.90%
Negative asset growth while PAAS invests at 20.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-33.48%
We have a declining book value while PAAS shows 32.61%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-190.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.